223 related articles for article (PubMed ID: 15101560)
1. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
[TBL] [Abstract][Full Text] [Related]
2. Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.
Pankow K; Wang Y; Gembardt F; Krause E; Sun X; Krause G; Schultheiss HP; Siems WE; Walther T
Circ Res; 2007 Oct; 101(9):875-82. PubMed ID: 17823376
[TBL] [Abstract][Full Text] [Related]
3. Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity.
Matsumura T; Kugiyama K; Sugiyama S; Ohgushi M; Amanaka K; Suzuki M; Yasue H
J Clin Invest; 1996 May; 97(10):2192-203. PubMed ID: 8636398
[TBL] [Abstract][Full Text] [Related]
4. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus.
Walther T; Stepan H; Pankow K; Gembardt F; Faber R; Schultheiss HP; Siems WE
BJOG; 2004 May; 111(5):452-5. PubMed ID: 15104609
[TBL] [Abstract][Full Text] [Related]
5. Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.
Kishimoto I; Hamra FK; Garbers DL
Can J Physiol Pharmacol; 2001 Aug; 79(8):715-22. PubMed ID: 11558680
[TBL] [Abstract][Full Text] [Related]
6. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
[TBL] [Abstract][Full Text] [Related]
8. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
9. Structural substrate conditions required for neutral endopeptidase-mediated natriuretic Peptide degradation.
Pankow K; Schwiebs A; Becker M; Siems WE; Krause G; Walther T
J Mol Biol; 2009 Oct; 393(2):496-503. PubMed ID: 19686760
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides and their therapeutic potential.
Cho Y; Somer BG; Amatya A
Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.
Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S
Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752
[TBL] [Abstract][Full Text] [Related]
12. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
Dickey DM; Potter LR
J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
[TBL] [Abstract][Full Text] [Related]
13. Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide.
Tamburini PP; Koehn JA; Gilligan JP; Charles D; Palmesino RA; Sharif R; McMartin C; Erion MD; Miller MJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):956-61. PubMed ID: 2532252
[TBL] [Abstract][Full Text] [Related]
14. [Activity and localization of neutral metalloendopeptidase (EC 3.4.24.11) (NEP), the degradative enzyme for atrial natriuretic peptide (ANP), in rat kidney].
Kanazawa M; Yasujima M; Kohzuki M; Abe K
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):791-9. PubMed ID: 8072216
[TBL] [Abstract][Full Text] [Related]
15. Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase.
Smith MW; Espiner EA; Yandle TG; Charles CJ; Richards AM
J Endocrinol; 2000 Nov; 167(2):239-46. PubMed ID: 11054637
[TBL] [Abstract][Full Text] [Related]
16. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice].
Boomsma F; van den Meiracker AH
Ned Tijdschr Geneeskd; 2003 Apr; 147(16):743-8. PubMed ID: 12731463
[TBL] [Abstract][Full Text] [Related]
17. The role of natriuretic peptides in cardioprotection.
Nishikimi T; Maeda N; Matsuoka H
Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney.
Bukowska A; Lendeckel U; Krohn A; Keilhoff G; ten Have S; Neumann KH; Goette A
Europace; 2008 Oct; 10(10):1212-7. PubMed ID: 18689805
[TBL] [Abstract][Full Text] [Related]
19. Degradation and inactivation of rat atrial natriuretic peptide 1-28 by neutral endopeptidase-24.11 in rat pulmonary membranes.
Lindberg BF; Bengtsson HI; Lundin S; Andersson KE
Regul Pept; 1992 Nov; 42(1-2):85-96. PubMed ID: 1475409
[TBL] [Abstract][Full Text] [Related]
20. Proadrenomedullin N-terminal 20 peptide is rapidly cleaved by neutral endopeptidase.
Nagatomo Y; Kitamura K; Kangawa K; Fujimoto Y; Eto T
Biochem Biophys Res Commun; 1996 Jun; 223(3):539-43. PubMed ID: 8687431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
